Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells

Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells

Modulation of β-catenin signaling has attractive therapeutic potential in cancer immunotherapy. Several studies have found that β-catenin can mediate immune evasion in cancer and promote anti-inflammatory features of antigen-presenting dendritic cells. Many small molecular compounds that inhibit Wnt...

Full description

Bibliographic Details
Main Authors:	Waqas Azeem, Ragnhild Maukon Bakke, Benjamin Gabriel, Silke Appel, Anne Margrete Øyan, Karl-Henning Kalland
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Biomedicines
Subjects:	monocyte-derived dendritic cell beta-catenin ICG-001 axitinib nitazoxanide
Online Access:	https://www.mdpi.com/2227-9059/9/8/949

Similar Items

Dual Pro- and Anti-Inflammatory Features of Monocyte-Derived Dendritic Cells
by: Waqas Azeem, et al.
Published: (2020-03-01)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
by: Geoffroy Danieau, et al.
Published: (2021-05-01)

Inhibition of β-Catenin/CREB Binding Protein Signaling Attenuates House Dust Mite-Induced Goblet Cell Metaplasia in Mice
by: Virinchi N. S. Kuchibhotla, et al.
Published: (2021-07-01)

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
by: Vinay K. Kartha, et al.
Published: (2018-07-01)

Antitumor Activity of Nitazoxanide against Colon Cancers: Molecular Docking and Experimental Studies Based on Wnt/β-Catenin Signaling Inhibition
by: Noha M. Abd El-Fadeal, et al.
Published: (2021-05-01)

The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300
by: Agnes I. Lukaszewicz, et al.
Published: (2019-07-01)

Activity of Nitazoxanide Against Viral Gastroenteritis: A Systematic Review
by: Eugene Tan, et al.
Published: (2017-08-01)

Comparison Between Nitazoxanide and Metronidazole in the Treatment of Protozoal Diarrhea in Children
by: Asmaa A.E. Ali, et al.
Published: (2014-06-01)

PH EFFECT ON STABILITY AND KINETICS DEGRADATION OF NITAZOXANIDE IN SOLUTION
by: Fábio Barbosa, et al.
Published: (2020-07-01)

Pulmonary cryptosporidiosis in an immunocompetent host treated successfully with nitazoxanide
by: Harish Kumar, et al.
Published: (2016-01-01)

Cryptosporidial diarrhea in an immunocompetent adult: role of nitazoxanide
by: Naba Raj Mainali, et al.
Published: (2013-12-01)

The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide
by: Claudio Fenizia, et al.
Published: (2021-07-01)

NITAZOXANIDE IN TREATMENT OF ROTAVIRUS DIARRHEA IN CHILDREN: A SINGLE CENTER STUDY
by: Aneeqa Adnan, et al.
Published: (2021-08-01)

Development of a simple, rapid and validated spectrophotometric method for nitazoxanide in pharmaceutical formulations and comparison with HPLC
by: Marcelo Donadel Malesuik, et al.
Published: (2010-01-01)

Efficacy of Nitazoxanide Alone or Loaded with Silica Nanoparticle for Treatment of Cryptosporidiosis in Immunocompetent Hosts
by: Alaa Metawae, et al.
Published: (2021-04-01)

ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population
by: Yi Liu, et al.
Published: (2017-09-01)

Design, Synthesis, and Biological Evaluation of Axitinib Derivatives
by: Na Wei, et al.
Published: (2018-03-01)

Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats
by: María Isabel Ruiz-Olmedo, et al.
Published: (2017-03-01)

Comparison of Therapeutic Effect of Anti-Cryptosporidium Nano-Nitazoxanide (NTZ) with Free form of this Drug in Neonatal Rat
by: F. Sedighi, et al.
Published: (2016-09-01)

Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?
by: Jessie Ehrisman, et al.
Published: (2013-09-01)

Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
by: Dina B. Mahmoud, et al.
Published: (2020-07-01)

Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis
by: Amal FarahatAllam, et al.
Published: (2020-04-01)

Synthesis, in vitro bioassays, and computational study of heteroaryl nitazoxanide analogs
by: Tasmia Ahmed, et al.
Published: (2021-05-01)

Simultaneous determination of Nitazoxanide and Ofloxacin in pharmaceutical preparations using UV-spectrophotometric and high performance thin layer chromatography methods
by: Smita Sharma, et al.
Published: (2017-02-01)

Glioblastoma Cells Do Not Affect Axitinib-Dependent Senescence of HUVECs in a Transwell Coculture Model
by: Matilde Merolle, et al.
Published: (2020-02-01)

Axitinib in metastatic renal cell carcinoma: single center experience
by: Agnieszka Buraczewska, et al.
Published: (2017-01-01)

Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
by: Chau V, et al.
Published: (2020-08-01)

HPLC method development and validation for the estimation of axitinibe in rabbit plasma
by: Achanta Suneetha, et al.
Published: (2017-10-01)

Axitinib in sequential therapy in metastatic renal cell carcinoma
by: Agata Kuchar, et al.
Published: (2015-05-01)

Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells
by: Jane L. Roberts, et al.
Published: (2021-09-01)

Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
by: Ibon Gurruchaga Sotés, et al.
Published: (2021-06-01)

Inhibition of Brazilian ZIKV strain replication in primary human placental chorionic cells and cervical cells treated with nitazoxanide
by: Audrien A.A. de Souza, et al.
Published: (2020-11-01)

Oxidative stress suppression contributes to antiseizure action of axitinib and rapamycin in pentylenetetrazol-induced kindling
by: O. B. Poshyvak, et al.
Published: (2021-04-01)

Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib
by: Linda Heintze, et al.
Published: (2020-11-01)

Antiparasitic Activity of Mirazid, Myrrh Total Oil and Nitazoxanide Compared to Praziquantel on Schistosoma Mansoni: Scanning Electron Microscopic Study
by: Mona EL-SAYAD, et al.
Published: (2017-09-01)

Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection
by: Asuncion G. Ramos-Soriano, et al.
Published: (2015-01-01)

EFFICACY OF NITAZOXANIDE AGAINST Toxocara canis: LARVAL RECOVERY AND HUMORAL IMMUNE RESPONSE IN EXPERIMENTALLY INFECTED MICE
by: Susana A. Zevallos LESCANO, et al.
Published: (2015-08-01)

Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
by: Kazuyuki Numakura, et al.
Published: (2021-09-01)

Dissolution Advantage of Nitazoxanide Cocrystals in the Presence of Cellulosic Polymers
by: Reynaldo Salas-Zúñiga, et al.
Published: (2019-12-01)

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
by: Valentina Giudice, et al.
Published: (2020-12-01)